Humacyte
Price & Volume
Stats
See more52W Range | $0.88-$4.14 |
Market Cap | $181M |
Shares Short | 37M |
Financials
See moreRevenue (12 Mos) | $1.5M |
Revenue Growth (YoY) | -100% |
Gross Profit (12 Mos) | -$73.8M |
Diluted EPS | -$0.27 |
News
See moreYahoo Finance • 13 hours ago
Sector Update: Health Care Stocks Decline Monday Afternoon
Yahoo Finance • 15 hours ago
Humacyte jumps as U.S. legislation backs bioengineered vessels
Yahoo Finance • 19 hours ago
Humacyte Announces New U.S. Department of Defense Funding for Procurement of Bioengineered Blood Vessels
Yahoo Finance • 2 months ago
Humacyte Announces Publication of Long-Term Safety and Efficacy Results of Symvess® in Extremity Trauma Repair
About
CEO | Dr. Laura E. Niklason M.D., Ph.D. |
CFO | Mr. Dale A. Sander |
Address | 2525 East North Carolina Highway 54, Durham, NC, United States, 27713 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 218 |
